Inhibition of Staphylococcus epidermidis Biofilms Using Polymerizable Vancomycin Derivatives
Biofilm formation on indwelling medical devices is a ubiquitous problem causing considerable patient morbidity and mortality. In orthopaedic surgery, this problem is exacerbated by the large number and variety of material types that are implanted. Metallic hardware in conjunction with polymethylmethacrylate (PMMA) bone cement is commonly used.
We asked whether polymerizable derivatives of vancomycin might be useful to (1) surface modify Ti-6Al-4V alloy and to surface/bulk modify PMMA bone cement to prevent Staphylococcus epidermidis biofilm formation and (2) whether the process altered the compressive modulus, yield strength, resilience, and/or fracture strength of cement copolymers.
A Ti-6Al-4V alloy was silanized with methacryloxypropyltrimethoxysilane in preparation for subsequent polymer attachment. Surfaces were then coated with polymers formed from PEG(375)-acrylate or a vancomycin-PEG(3400)-PEG(375)-acrylate copolymer. PMMA was loaded with various species, including vancomycin and several polymerizable vancomycin derivatives. To assess antibiofilm properties of these materials, initial bacterial adherence to coated Ti-6Al-4V was determined by scanning electron microscopy (SEM). Biofilm dry mass was determined on PMMA coupons; the compressive mechanical properties were also determined.
SEM showed the vancomycin-PEG(3400)-acrylate-type surface reduced adherent bacteria numbers by approximately fourfold when compared with PEG(375)-acrylate alone. Vancomycin-loading reduced all mechanical properties tested; in contrast, loading a vancomycin-acrylamide derivative restored these deficits but demonstrated no antibiofilm properties. A polymerizable, PEGylated vancomycin derivative reduced biofilm attachment but resulted in inferior cement mechanical properties.
The approaches presented here may offer new strategies for developing biofilm-resistant orthopaedic materials. Specifically, polymerizable derivatives of traditional antibiotics may allow for direct polymerization into existing materials such as PMMA bone cement while minimizing mechanical property compromise. Questions remain regarding ideal monomer structure(s) that confer biologic and mechanical benefits.
KeywordsVancomycin PMMA Bone Cement Compressive Modulus Periprosthetic Joint Infection
Biofilms have been referred to as the “hallmark characteristic of periprosthetic joint infection” . One report suggests many cases of presumed aseptic prosthetic loosening may actually be the result of undetected biofilms . The antibiotic concentration required for bactericidal activity against sessile organisms can be several orders of magnitude higher than for planktonic bacteria , the rule of thumb being 1000 to 1500 times higher . This places a premium on extensive wound irrigation and débridement at the time of surgery followed by lengthy antibiotic therapy.
A classic strategy used in orthopaedic infections, including those of biofilm origin, relies on loading polymethylmethacrylate (PMMA) bone cement with antibiotics that elute in vivo [4, 12, 13, 17, 18, 24, 26, 27, 29, 35, 37, 41, 42, 49, 50, 66]. Antibiotic-loaded bone cements tend to release entrapped pharmaceuticals in a burst-type fashion and, hence, are effective at delivering high local levels of an antibacterial agent for a short postimplantation period, usually a few days [4, 12, 37, 41, 66]. When loaded at high dose, effective antibiotic levels may be maintained in surrounding tissues for several months [1, 30, 41]. However, high-dose loading compromises mechanical behavior of bone cements [12, 26, 35] likely through direct physical changes in material architecture related to the addition of nonpolymerizable species. Antibiotic-loaded PMMA may continue to elute therapeutic agents for weeks or months at suboptimal levels. These problems may be partially overcome by adding water-soluble fillers that increase cement porosity and facilitate antibiotic release, and vacuum processing techniques can lead to more homogenous cement compositions [9, 43, 46]. Unfortunately, bone cement has a surface quite suitable for colonization, and although antibiotic loading can reduce biofilm formation, organisms are still able to grow, for example, on gentamicin-loaded bone cements [33, 61].
Additionally, there is much literature dedicated to polymeric surface modification of metal oxides, including those of titanium, with the goal of blocking protein adhesion and bacterial attachment [15, 22, 28, 40, 54]. Derivatives of poly(ethylene glycol) (PEG) are common in these antibiofouling and antibiofilm strategies [11, 15, 19, 22, 28, 40, 54, 62, 65]. PEG blocks the nonspecific adsorption of proteins, cells, and cellular debris through mechanisms generally attributed to its hydrophilic character and high surface mobility (steric repulsion) [2, 36, 52]. It is particularly attractive in biomaterial systems because PEG is nontoxic  and well tolerated at high doses . Polymerizable derivatives of traditional therapeutics potentially offer a convenient advantage over other compounds in that they can be polymerized to implant materials such as Ti-6Al-4V alloy  or copolymerized with polymeric biomaterials to provide surface-active antibiotic moieties .
We asked whether (1) vancomycin-PEG(3400)-acrylate [VPA(3400)] polymerized to Ti-6Al-4V alloy reduces bacterial attachment with respect to PEG controls; (2) whether the antibiofilm effects of VPA(3400) and two vancomycin-acrylamide derivatives when individually copolymerized with PMMA bone cement would be statistically superior to vancomycin loading in terms of reduced adherent biofilm mass; and (3) whether polymerizable antibiotics when incorporated into PMMA would yield cement constructs with compressive mechanical properties similar to PMMA homopolymer and statistically superior to vancomycin-loaded PMMA.
Materials and Methods
Vancomycin was loaded into “C~ment 1” PMMA bone cement (Jorgensen Laboratories, Inc, Loveland, CO) at a concentration of 1 g vancomycin to 40 g bone cement powder (2.5 wt%, a standard, prophylactic loading dose) or at a concentration of 4 g to 40 g bone cement powder (10 wt%, a high, therapeutic loading dose). VPA(3400), VA-1, VA-2, and PEG(3000)-acrylate were loaded at 10 wt%. Cylinders were constructed by first dissolving the desired additive in water and mixing with bone cement powder to create a slurry. The slurry was then flash-frozen using liquid nitrogen and lyophilized to recover a homogeneous powder. Bone cement cylinders were polymerized by addition of monomer liquid according to the manufacturer’s directions. Cylinders of dimensions 10 mm × 5 mm (height × diameter) were formed using a Teflon mold.
Substrates (polymer-coated Ti alloy) were placed in 50 mL brain heart infusion (BHI) medium, and the medium was inoculated with Staphylococcus epidermidis ATCC 35984 (clinical, biofilm-forming isolate). BHI medium was used in previous studies of polymerizable vancomycin derivatives [38, 39] and, for consistency, was used here. Samples were incubated on a rotary shaker at 100 rpm at 37°C. Polymer-coated Ti samples were allowed to incubate for 24 or 72 hours. Twenty-four-hour samples were removed, rinsed with copious amounts of water to wash away unbound organisms, and prepared for SEM. Seventy-two-hour specimens were inspected visually. The SEM preparatory procedure consisted of 1-hour fixation in 10% (v/v) phosphate-buffered formalin (Fisher Scientific, Kalamazoo, MI) followed by an ethanol dehydration series: 15 minutes in 50:50 ethanol:H2O, 15 minutes in 75:25 ethanol:H2O, 15 minutes in 95:5 ethanol:H2O, and 30 minutes in 100% ethanol. The samples were then placed in hexamethyldisilazane (Electron Microscopy Sciences, Hatfield, PA) for 1 hour 45 minutes, removed, frozen, lyophilized, and gold-coated. SEM images were obtained at 750x magnification using a JSM-6480LV system (JOEL Ltd, Tokyo, Japan). A minimum of 10 random images was taken of each sample coupon by panning the microscope to non-predetermined regions about the test coupon and then quantifying adherent organisms. Organisms were not visible during the panning procedure, only when the microscope came to a complete stop. Adherent Staphylococcal organisms were counted, and an average surface density was calculated for each coupon using area measurements from ImageJ Version 1.33u software (National Institutes of Health, Bethesda, MD). This approach was repeated for each Ti sample of varying surface type.
PMMA cylinders were incubated analogously except they were transferred to fresh media every 22 hours. Twenty-two hours was chosen as a time point for media collection as this marked the onset of bacterial suspension turbidity, and there was concern for inappropriate bacterial death with incubation under turbid conditions. At 22, 44, 66, and 88 hours, cylinders were collected, freeze-dried before adherent biofilm mass was determined gravimetrically (biofilm dry weight) to the closest 1/10 milligram using a standard analytical balance and a modification of methods described elsewhere . We used 4-day growth data for comparing surface types. Vancomycin-loaded cylinders released active antibiotic for the first 22 hours at levels sufficient to inhibit bacterial growth in the incubation vessel as these vancomycin-containing vessels did not go on to reach turbidity if allowed to incubate further. However, if fresh media were supplied, bacterial growth commenced over subsequent time intervals. Accordingly, for vancomycin-loaded samples, reported time points were adjusted by subtracting 22 hours and represent hours after observed burst elution.
PMMA and PMMA-composite compressive mechanical properties were measured using an MTS 858 MiniBionix II system (MTS Systems Corp, Eden Prairie, MN) with a platen speed of 1 mm/min. Stress strain data were analyzed external to the system software. Compressive modulus was calculated as the slope of the elastic deformation region using a standard linear least squares fit. Yield strength (stress at the transition between elastic and plastic deformation) was calculated using a 0.002 offset method. Resilience was calculated as the area under the stress-strain curve up to yield strength. Fracture strength, when applicable, was taken as the stress at catastrophic failure.
We determined by SEM differences in the average number of adherent S. epidermidis organisms between Ti alloy surfaces coated with PEG(375)-acrl (n = 6) and VPA(3400)-PEG(375)-acrl (n = 7) using the Student’s t-test. We determined differences in adherent biofilm dry mass between PMMA cylinders (n = 11), PMMA cylinders incorporating vancomycin at 2.5 wt% (n = 3), vancomycin at 10 wt% (n = 10), VPA(3400) at 10 wt% (n = 10), VA-1 at 10 wt% (n = 5), VA-2 at 10 wt% (n = 9), or PEG(3000)-acrylate at 10 wt% (n = 9) using the one-way analysis of variance (ANOVA) in combination with the Tukey Test for pairwise comparisons. We determined differences in compressive modulus, yield strength, resilience, fracture strength, and strain at fracture between PMMA coupons (n = 5), PMMA coupons incorporating vancomycin 10 wt% (n = 5), VPA(3400) 10 wt% (n = 5), PEG(3000)-Acrl 5 wt% (n = 5), PEG(3000)-Acrl 10 wt% (n = 5), and VA-2 10 wt% (n = 3) using the one-way ANOVA in combination with the Tukey test for pairwise comparisons. Levine’s test was used to check the assumption of equal sample variances, and the Kolmogorov-Smirnov test along with visual examination of normal probability plots was used to verify data normality for all ANOVA analyses.
Compressive mechanical properties for PMMA bone cement with various additives are shown. VA-2 composite properties are very similar to those of PMMA. Species with PEG functionalities lead to mechanical property compromise
Compressive modulus (MPa)
Yield strength (MPa)
Fracture strength (MPa)
Strain at fracture (%)
25 ± 1 (100%)
85 ± 3 (100%)
3.0 ± 0.2 (100%)
96 ± 13 (100%)
31 ± 7 (100%)
20 ± 1 (80%)
71 ± 2 (84%)
2.5 ± 0.3 (83%)
57 ± 5 (59%)
20 ± 3 (65%)
28.2 ± 0.4 (113%)
87 ± 1 (102%)
2.8 ± 0.3 (93%)
90 ± 2 (94%)
31 ± 3 (100%)
16 ± 3 (64%)
53 ± 2 (62%)
1.7 ± 0.2 (57%)
76 ± 8 (79%)*
34 ± 2 (110%)*
20.7 ± 0.5 (83%)
59 ± 2 (69%)
1.9 ± 0.1 (63%)
72 ± 6 (75%)*
33 ± 3 (106%)*
15 ± 1 (60%)
44 ± 4 (52%)
1.4 ± 0.2 (47%)
50 ± 7 (52%)*
27 ± 6 (87%)*
Biofilm-forming organisms continue to be a central concern in orthopaedic procedures which involve the placement of metallic hardware in conjunction with PMMA bone cement. We present initial work to evaluate the usefulness of vancomycin-PEG-acrylate and vancomycin-acrylamide species for the inhibition of S. epidermidis biofilm formation on both Ti-6Al-4V orthopaedic alloy and on PMMA bone cement.. We evaluated: (1) whether VPA(3400) polymerized to Ti-6Al-4V alloy reduces bacterial attachment; (2) the antibiofilm effects (reduced biofilm mass) of VPA(3400) and two vancomycin-acrylamide derivatives when individually copolymerized with PMMA bone cement; and (3) the compressive mechanical effects of adding polymerizable antibiotics to PMMA bone cement.
We acknowledge limitations to our experiment. First is that the biofilm growth conditions presented may not reflect those encountered in vivo. A biofilm bioreactor might offer a more sophisticated approach to simulating growth conditions [3, 10, 34]. However, it is inherently difficult to define the complex milieu of an infection site, and the assays used here were sufficient to define differences between material types. Second, the traditional method of quantifying adherent biofilm is by measurement of viability by prior desorption (ultrasonication) and subsequent agar plating , though there is often considerable variability in the absolute bacterial count obtained by different methods . Quantification by SEM is often limited  secondary to problems of bacterial enumeration arising from bacterial agglomerates and matrix-embedded bacteria [25, 55, 60] and from the possibility that some of the biofilm structure will be lost during preparation [23, 63]. For this reason, our SEM quantification methods were limited to measurement of initial bacterial attachment where extensive glycocalyx was not present and where relative bacterial surface density was low. We expect the reported bacterial surface densities (Fig. 5) to be technique dependent as with other methods . Dry mass has also been used to quantify biofilm proliferation [51, 59]; however, the gravimetric assay used here to evaluate adherent biofilm mass on PMMA surfaces does not provide adequate precision for discriminating between the effects of VPA(3400) and PEG(3000)-acrylate. Third, although we demonstrated various statistically significant effects attributable to polymerizable antibiotic species, whether these effects will have clinical importance is a question for future work.
In experiments with polymer-coated Ti alloy, VPA(3400) appears to add an additional level of protection to PEG-type coatings (Fig. 5). Surface-contact killing may contribute to the decreased number of adherent bacteria during the initial stages of biomaterial colonization. It is likely this period is critical in true physiological infections in which the bacterial load in the surrounding fluids is generally expected to be low. In comparison, a recently described antimicrobial technique involves the covalent attachment of an antibiotic (presumably a monolayer) to titanium [5, 6, 7, 21, 32, 47]. Building on surface modification methods described by Nanci et al. , the authors were able to attach vancomycin to titanium via two aminoethoxyethoxyacetate linkers. One study suggested Staphylococcus aureus attachment may be blocked using this surface-modification platform . However, because aminoethoxyethoxyacetate linkers (sold commercially as “Mini-PEG”) effectively put a thin PEG layer on a surface (four ethylene glycol units), some of the observed antibiofilm properties may be related to the linker chemistry. Another study reported as few as four ethylene glycol repeats can provide antibiofouling properties for 3 weeks or longer with some cell types .
The data show incorporation of PEG moieties into the PMMA architecture retards but ultimately does not prevent biofilm adherence. This effect may be related to blockage of initial bacterial attachment, as suggested in other studies with PMMA [16, 53], but may be overcome as the surface is saturated with bacterial glycocalyx and cellular debris. Neither of the vancomycin-acrylamide derivatives showed an antibiofilm effect. This behavior is consistent with previous observations  suggesting the PEG linker is critical for antibacterial activity once vancomycin derivatives are polymerized from solid substrates. In an alternative approach, a quaternary amine dimethacrylate (QADMA) species was copolymerized with PMMA bone cement, and antibiofilm properties against Escherichia coli were examined [16, 53], but no quantification of adherent organisms was undertaken. Data suggested QADMA blocked the attachment of Escherichia coli; whether this was related to the killing of microorganisms is less clear.
Mechanical testing of antibiotic-loaded bone cements (Table 1) confirms that adding vancomycin at 10 wt% decreases compressive modulus, yield strength, resilience, and fracture strength, which is consistent with previous reports [12, 26, 35]; for example, Klekamp et al.  showed that, in fatigue tests, loading vancomycin at 7.5 wt% decreased the number of cycles to failure by 50%. Substituting the acrylamide-modified vancomycin derivative VA-2 at 10 wt% restores all measured mechanical deficits and may actually increase the compressive modulus. These improvements likely occur because the acrylamide functionality copolymerizes with methacrylate groups during bone cement curing, whereas vancomycin does not. Conversely, vancomycin may leave gross structural cavities in the cement or act as a plasticizer. Unfortunately, VA-2 and VA-1 were not effective at blocking biofilm formation in the assay presented here, suggesting it was the PEG functionality that conferred antibiofilm properties and also mechanically compromised the cements. PEG is known to confer resistance to cellular or protein attachment [19, 22, 65], and the PEG tether is reportedly important for increasing surface-based activity of VPA-type species . There may be some optimal number of ethylene glycol units that confers adequate antibacterial activity without sacrificing bone cement mechanical integrity.
Data with coated Ti alloy surfaces suggest copolymerizing a PEGylated vancomycin species, VPA(3400), with PEG(375)-acrylate is more effective than PEG alone at blocking S. epidermidis biofilms. The PEG spacer itself likely contributes to the antibiofilm effect, but SEM data indicate the pendant vancomycin molecule improves the antimicrobial effect under some growth conditions. Loading PMMA bone cement with certain polymerizable vancomycin derivatives may eventually be useful for retarding biofilm adherence without compromising mechanical properties, although the current formulations did one or the other, but not both. A vancomycin-acrylamide additive resulted in compressive mechanical properties almost identical to PMMA controls but did not inhibit biofilm growth. VPA(3400) reduced biofilm growth but compromised mechanical properties. Experiments described here should facilitate the development of new antibiofilm biomaterial surfaces.
We thank J. McCormick for assistance with XPS surface characterization.
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
- 8.Antonios V, Berbari E, Osmon D. Treatment protocol of infections of orthopedic devices. In: Pace JL, Rupp ME, Finch RG, eds. Biofilms, Infection, and Antimicrobial Therapy. Boca Raton, FL: CRC Press; 2006:449–478.Google Scholar
- 21.Edupuganti OP, Antoci V, Jr., King SB, Jose B, Adams CS, Parvizi J, Shapiro IM, Zeiger AR, Hickok NJ, Wickstrom E. Covalent bonding of vancomycin to Ti6Al4V alloy pins provides long-term inhibition of Staphylococcus aureus colonization. Bioorg Med Chem Lett. 2007;17:2692–2696.CrossRefPubMedGoogle Scholar